Literature DB >> 35035685

METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.

Yaqin Li1, Xianyi Cheng2, Yihua Chen1, Tao Zhou2, Dezhi Li2, Wei V Zheng2.   

Abstract

OBJECTIVE: To explore whether METTL3 was involved in the pathogenesis of hepatocellular carcinoma (HCC) by modulating the m6A level of USP7.
METHODS: We performed qRT-PCR and western blot assays to detect the expression level of METTL3 in HCC tissues and paired adjacent normal tissues, as well as HCC cell lines. The level of m6A in HCC tissues and cells was quantitatively analyzed by m6A RNA Methylation Quantitative Kit. We examined the effect of METTL3 on cell proliferation ability by CCK-8 and EdU assays, and examined cell migration and cell invasion ability by Transwell assay. It was predicted via bioinformatics tool that USP7 may undergo methylation in HCC. Subsequently, we performed qRT-PCR assay to detect the expression level of USP7 in HCC tissues and analyzed its correlation with the expression level of METTL3. We verified the regulatory relationship between METTL3/USP7 and transfected USP7 siRNA in cells to detect its effects on cell invasion, migration and proliferation. The regulatory effect of METTL3 on USP7 in HCC was analyzed by corresponding experiments.
RESULTS: The qRT-PCR results indicated that METTL3 was highly expressed in HCC tissues and cell lines. The level of m6A was remarkably increased in HCC tissues and cell lines. Besides, the elevated METTL3 expression was related to worse overall survival. The abilities of cell invasion, migration and proliferation were remarkably attenuated by down-regulation of METTL3 expression. Through bioinformatics analysis, it was found that USP7 might be regulated by METTL3 to undergo methylation modification. The qRT-PCR results showed that the USP7 was highly expressed in HCC tissues, and was positively correlated with the level of METTL3. Further experiments showed that down-regulation of USP7 could reduce cell proliferation, migration, and invasion. METTL3 could positively regulate the malignant phenotype of USP7 in HCC.
CONCLUSION: METTL3 might regulate the expression of USP7 through m6A methylation and facilitate the invasion, migration and proliferation of HCC cells. AJTR
Copyright © 2021.

Entities:  

Keywords:  METTL3; RNA methylation; cell invasion; cell migration; cell proliferation

Year:  2021        PMID: 35035685      PMCID: PMC8748139     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  44 in total

Review 1.  Gene expression regulation mediated through reversible m⁶A RNA methylation.

Authors:  Ye Fu; Dan Dominissini; Gideon Rechavi; Chuan He
Journal:  Nat Rev Genet       Date:  2014-03-25       Impact factor: 53.242

2.  A model for NADH-tetrazolium reductase. Histochemical implications of light-induced electron transfer in NADH-riboflavin-tetrazolium complexes.

Authors:  M Niemi; K K Mustakallio
Journal:  Histochemie       Date:  1965-01-12

3.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

4.  Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.

Authors:  A Visvanathan; V Patil; A Arora; A S Hegde; A Arivazhagan; V Santosh; K Somasundaram
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

5.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility.

Authors:  Guanqun Zheng; John Arne Dahl; Yamei Niu; Peter Fedorcsak; Chun-Min Huang; Charles J Li; Cathrine B Vågbø; Yue Shi; Wen-Ling Wang; Shu-Hui Song; Zhike Lu; Ralph P G Bosmans; Qing Dai; Ya-Juan Hao; Xin Yang; Wen-Ming Zhao; Wei-Min Tong; Xiu-Jie Wang; Florian Bogdan; Kari Furu; Ye Fu; Guifang Jia; Xu Zhao; Jun Liu; Hans E Krokan; Arne Klungland; Yun-Gui Yang; Chuan He
Journal:  Mol Cell       Date:  2012-11-21       Impact factor: 17.970

6.  HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG.

Authors:  Chuan-Dong Cheng; Yong-Fei Dong; Wan-Xiang Niu; Chao-Shi Niu
Journal:  Pathol Res Pract       Date:  2020-02-13       Impact factor: 3.250

7.  Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis.

Authors:  Nuo Li; Zhifeng Zhao; Pengliang Liu; Yan Zheng; Shuang Cai; Yin Sun; Baoming Wang
Journal:  Mol Ther Oncolytics       Date:  2020-12-25       Impact factor: 7.200

8.  Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer.

Authors:  Su H Park; Ka-Wing Fong; Jung Kim; Fang Wang; Xiaodong Lu; Yongik Lee; Lourdes T Brea; Kristine Wadosky; Chunming Guo; Sarki A Abdulkadir; John D Crispino; Deyu Fang; Panagiotis Ntziachristos; Xin Liu; Xue Li; Yong Wan; David W Goodrich; Jonathan C Zhao; Jindan Yu
Journal:  Sci Adv       Date:  2021-04-07       Impact factor: 14.136

View more
  4 in total

Review 1.  Research Progress of DUB Enzyme in Hepatocellular Carcinoma.

Authors:  Jie Zhao; Jinhui Guo; Yanan Wang; Qiancheng Ma; Yu Shi; Feng Cheng; Qiliang Lu; Wen Fu; Guangxiong Ouyang; Ji Zhang; Qiuran Xu; Xiaoge Hu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

2.  The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.

Authors:  Dan Li; Kai Li; Wei Zhang; Kong-Wu Yang; De-An Mu; Guo-Jun Jiang; Rong-Shu Shi; Di Ke
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 3.  The role of RNA modification in hepatocellular carcinoma.

Authors:  Qiang Feng; Dongxu Wang; Tianyi Xue; Chao Lin; Yongjian Gao; Liqun Sun; Ye Jin; Dianfeng Liu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

4.  Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.

Authors:  Yaqing Zhou; Rongli Jiang; Yali Jiang; Yahong Fu; Yerbolat Manafhan; Jinfu Zhu; Enzhi Jia
Journal:  Cells       Date:  2022-09-24       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.